In this present study, we show that oral administration of human therapeutic doses of cetirizine (1 mg/kg b.w) or fexofenadine (10 mg/kg b.w) in ApoE−/− mice for three months did not reduce progression of atherosclerosis, instead, increased the atherosclerotic lesion formation. The gene discussed is APOE; the disease is atherosclerosis.